2024-09-10 - Analysis Report
## Abbott Laboratories (ABT) Stock Analysis

**Company Overview:** Abbott Laboratories is a multinational pharmaceutical and medical device company that develops, manufactures, and sells a wide range of healthcare products.

**Performance Analysis:**

**1. Relative Performance:**

* ABT's cumulative return of 42.44% is **significantly lower** than the S&P 500's cumulative return of 81.34%.
* This lag is reflected in the **negative relative performance** (-38.9%) which is currently **below average** compared to its historical range (-53.92 to 25.37).
* This indicates that ABT has underperformed the market in the past period.

**2. Recent Price Trend:**

* ABT's recent price trend is **relatively stable**, with the closing price (113.86) close to the 5-day moving average (113.86).
* The price is **slightly above** the 20-day moving average (111.81) and **significantly higher** than the 60-day moving average (107.22).
* This suggests potential upward momentum in the short term.

**3. Technical Indicators:**

* **RSI (66.03):**  The RSI suggests the stock is in the **overbought territory**, indicating potential for a short-term correction.
* **PPO (-0.05):** A negative PPO value indicates **potential for a downward trend**.
* **Delta_Previous_Relative_Divergence (2.27):** A positive value indicates **potential short-term upward movement** in the relative performance compared to the S&P 500.
* **Expected Return (24.1%):** The expected return suggests a **potential for significant gains** over the next 5 years.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-31 | 0.74 | 10.38 B$ |
| 2024-05-02 | 0.7 | 9.96 B$ |
| 2023-11-01 | 0.82 | 10.14 B$ |
| 2023-08-03 | 0.79 | 9.98 B$ |
| 2024-07-31 | 0.79 | 9.98 B$ |

* ABT's recent earnings have been **stable**, with revenue slightly increasing.
* **The most recent earnings report (2024-07-31)** showed an EPS of 0.74, which **slightly exceeded analyst expectations**. 
* **Overall, the recent earnings trend is positive**, indicating that the company is performing well financially.

**5. Summary Analysis:**

ABT's stock performance has lagged the market in the recent period, although it shows potential for short-term upward movement. While recent earnings have been stable and above analyst expectations, technical indicators suggest potential for a short-term correction. However, the stock's strong expected return and relatively stable earnings make it a potential investment for long-term growth.

**6. Final Considerations:**

It's crucial to conduct further research and consider your individual investment goals and risk tolerance before making any investment decisions.  Consult with a financial professional for personalized advice. 
